Screener
Eligibility screening
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
1 US site in PA
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.
Screener
Topical Ruxolitinib 1.5% for Hidradenitis Suppurativa Treatment
1 US site in PA
Before we begin
Your answer affects how the questions are phrased.